Ultragenyx Pharmaceutical LLC
By
Deborah Erickson / Email the Author / START-UP May 2011, Vol. 16, No. 5
Grouped Start-Ups / Word Count: 1589 / Article # 2011900103
Executive Summary
Biotech veteran Emil Kakkis founded Ultragenyx Pharmaceutical LLC to develop treatments for rare disorders. First up: a potential therapy for hereditary inclusion body myopathies. There are several variants of this neuromuscular disorder, which causes progressive muscle weakness. By the end of the disease course, patients can be almost quadriplegic in terms of motor function. Ultragenyx is betting it can help restore muscle function in people diagnosed with HIBM by providing a continuous and steady source of sialic acid, likely through thrice-daily oral administration.
$85.00
Buy Now
For $85.00, purchase this 1589-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.